412 related articles for article (PubMed ID: 37602192)
1. Development of brain organoid technology derived from iPSC for the neurodegenerative disease modelling: a glance through.
Jusop AS; Thanaskody K; Tye GJ; Dass SA; Wan Kamarul Zaman WS; Nordin F
Front Mol Neurosci; 2023; 16():1173433. PubMed ID: 37602192
[TBL] [Abstract][Full Text] [Related]
2. 3D brain Organoids derived from pluripotent stem cells: promising experimental models for brain development and neurodegenerative disorders.
Lee CT; Bendriem RM; Wu WW; Shen RF
J Biomed Sci; 2017 Aug; 24(1):59. PubMed ID: 28822354
[TBL] [Abstract][Full Text] [Related]
3. Opportunities and challenges for the use of induced pluripotent stem cells in modelling neurodegenerative disease.
Wu YY; Chiu FL; Yeh CS; Kuo HC
Open Biol; 2019 Jan; 9(1):180177. PubMed ID: 30958120
[TBL] [Abstract][Full Text] [Related]
4. Central nervous system organoids for modeling neurodegenerative diseases.
Hou PS; Kuo HC
IUBMB Life; 2022 Aug; 74(8):812-825. PubMed ID: 35102668
[TBL] [Abstract][Full Text] [Related]
5. Modelling neurodegenerative diseases with 3D brain organoids.
Chang Y; Kim J; Park H; Choi H; Kim J
Biol Rev Camb Philos Soc; 2020 Oct; 95(5):1497-1509. PubMed ID: 32568450
[TBL] [Abstract][Full Text] [Related]
6. Advances in Central Nervous System Organoids: A Focus on Organoid-Based Models for Motor Neuron Disease.
Vieira de Sá R; Cañizares Luna M; Pasterkamp RJ
Tissue Eng Part C Methods; 2021 Mar; 27(3):213-224. PubMed ID: 33446055
[TBL] [Abstract][Full Text] [Related]
7. Modeling and Targeting Alzheimer's Disease With Organoids.
Papaspyropoulos A; Tsolaki M; Foroglou N; Pantazaki AA
Front Pharmacol; 2020; 11():396. PubMed ID: 32300301
[TBL] [Abstract][Full Text] [Related]
8. Studying Human Neurological Disorders Using Induced Pluripotent Stem Cells: From 2D Monolayer to 3D Organoid and Blood Brain Barrier Models.
Logan S; Arzua T; Canfield SG; Seminary ER; Sison SL; Ebert AD; Bai X
Compr Physiol; 2019 Mar; 9(2):565-611. PubMed ID: 30873582
[TBL] [Abstract][Full Text] [Related]
9. The Breakthroughs and Caveats of Using Human Pluripotent Stem Cells in Modeling Alzheimer's Disease.
Sahlgren Bendtsen KM; Hall VJ
Cells; 2023 Jan; 12(3):. PubMed ID: 36766763
[TBL] [Abstract][Full Text] [Related]
10. Induced Pluripotent Stem Cells and Organoids in Advancing Neuropathology Research and Therapies.
Pazzin DB; Previato TTR; Budelon Gonçalves JI; Zanirati G; Xavier FAC; da Costa JC; Marinowic DR
Cells; 2024 Apr; 13(9):. PubMed ID: 38727281
[TBL] [Abstract][Full Text] [Related]
11. The Evolving Role of Induced Pluripotent Stem Cells and Cerebral Organoids in Treating and Modeling Neurosurgical Diseases.
Jovanovich N; Habib A; Kodavali C; Edwards L; Amankulor N; Zinn PO
World Neurosurg; 2021 Nov; 155():171-179. PubMed ID: 34454068
[TBL] [Abstract][Full Text] [Related]
12. Human iPSC-Based Modeling of Central Nerve System Disorders for Drug Discovery.
Qian L; Tcw J
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33530458
[TBL] [Abstract][Full Text] [Related]
13. Human Pluripotent Stem Cells as In Vitro Models of Neurodegenerative Diseases.
Machairaki V
Adv Exp Med Biol; 2020; 1195():93-94. PubMed ID: 32468463
[TBL] [Abstract][Full Text] [Related]
14. Drug discovery using induced pluripotent stem cell models of neurodegenerative and ocular diseases.
Hung SSC; Khan S; Lo CY; Hewitt AW; Wong RCB
Pharmacol Ther; 2017 Sep; 177():32-43. PubMed ID: 28223228
[TBL] [Abstract][Full Text] [Related]
15. Reverse engineering human neurodegenerative disease using pluripotent stem cell technology.
Liu Y; Deng W
Brain Res; 2016 May; 1638(Pt A):30-41. PubMed ID: 26423934
[TBL] [Abstract][Full Text] [Related]
16. From Neuronal Differentiation of iPSCs to 3D Neuro-Organoids: Modelling and Therapy of Neurodegenerative Diseases.
Bordoni M; Rey F; Fantini V; Pansarasa O; Di Giulio AM; Carelli S; Cereda C
Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30544711
[TBL] [Abstract][Full Text] [Related]
17. Induced Pluripotent Stem Cells for Treatment of Alzheimer's and Parkinson's Diseases.
Yefroyev DA; Jin S
Biomedicines; 2022 Jan; 10(2):. PubMed ID: 35203418
[TBL] [Abstract][Full Text] [Related]
18. Enhanced Neuronal Activity and Asynchronous Calcium Transients Revealed in a 3D Organoid Model of Alzheimer's Disease.
Yin J; VanDongen AM
ACS Biomater Sci Eng; 2021 Jan; 7(1):254-264. PubMed ID: 33347288
[TBL] [Abstract][Full Text] [Related]
19. Disease Modeling Using 3D Organoids Derived from Human Induced Pluripotent Stem Cells.
Ho BX; Pek NMQ; Soh BS
Int J Mol Sci; 2018 Mar; 19(4):. PubMed ID: 29561796
[TBL] [Abstract][Full Text] [Related]
20. Recent advances for using human induced-pluripotent stem cells as pain-in-a-dish models of neuropathic pain.
Labau JIR; Andelic M; Faber CG; Waxman SG; Lauria G; Dib-Hajj SD
Exp Neurol; 2022 Dec; 358():114223. PubMed ID: 36100046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
